Skip to main content
. 2013 Apr 27;8(2):127–136. doi: 10.1007/s11523-013-0271-z

Fig. 5.

Fig. 5

Kaplan–Meier estimate of overall survival by KRAS status among BSC patients that did not crossover to panitumumab